These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28170220)

  • 1. Classics in Chemical Neuroscience: Haloperidol.
    Tyler MW; Zaldivar-Diez J; Haggarty SJ
    ACS Chem Neurosci; 2017 Mar; 8(3):444-453. PubMed ID: 28170220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classics in Chemical Neuroscience: Chlorpromazine.
    Boyd-Kimball D; Gonczy K; Lewis B; Mason T; Siliko N; Wolfe J
    ACS Chem Neurosci; 2019 Jan; 10(1):79-88. PubMed ID: 29929365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classics in Chemical Neuroscience: Ketamine.
    Tyler MW; Yourish HB; Ionescu DF; Haggarty SJ
    ACS Chem Neurosci; 2017 Jun; 8(6):1122-1134. PubMed ID: 28418641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classics in Chemical Neuroscience: Xanomeline.
    Bender AM; Jones CK; Lindsley CW
    ACS Chem Neurosci; 2017 Mar; 8(3):435-443. PubMed ID: 28141924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.
    Peprah K; Zhu XY; Eyunni SV; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2012 Feb; 20(3):1291-7. PubMed ID: 22245230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
    López-Muñoz F; Alamo C
    Brain Res Bull; 2009 Apr; 79(2):130-41. PubMed ID: 19186209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and mechanism of action of existing and new neuroleptics.
    Niemegeers CJ
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):26-36. PubMed ID: 1981439
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.
    Zanatta G; Nunes G; Bezerra EM; da Costa RF; Martins A; Caetano EW; Freire VN; Gottfried C
    ACS Chem Neurosci; 2014 Oct; 5(10):1041-54. PubMed ID: 25181639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of neuroreceptors in living human brain. v. endogenous neurotransmitter inhibition of haloperidol binding in psychosis.
    Gjedde A; Wong DF
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):982-94. PubMed ID: 11487734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
    Feng M; Sparkman NL; Sui N; Li M
    J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.
    Peprah K; Zhu XY; Eyunni SV; Etukala JR; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2012 Mar; 20(5):1671-8. PubMed ID: 22336245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol in palliative care.
    Vella-Brincat J; Macleod AD
    Palliat Med; 2004 Apr; 18(3):195-201. PubMed ID: 15198132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
    Blin O; Fakra E; Tardieu S; Micallef J
    Encephale; 2002; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
    [No Abstract]   [Full Text] [Related]  

  • 17. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.
    Schwalbe T; Kaindl J; Hübner H; Gmeiner P
    Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classics in Chemical Neuroscience: Methylphenidate.
    Wenthur CJ
    ACS Chem Neurosci; 2016 Aug; 7(8):1030-40. PubMed ID: 27409720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The discovery of haloperidol].
    Granger B
    Encephale; 1999; 25(1):59-66. PubMed ID: 10205735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
    Benvegnú DM; Barcelos RC; Boufleur N; Reckziegel P; Pase CS; Ourique AF; Beck RC; Bürger ME
    Eur J Pharm Biopharm; 2011 Feb; 77(2):332-6. PubMed ID: 21168486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.